{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:44:10Z","timestamp":1791924250844,"version":"4.3.4"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bioorg.2026.109818","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T06:57:11Z","timestamp":1775026631000},"page":"109818","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Utility of FRET substrates in bladder cancer diagnosis"],"prefix":"10.1016","volume":"175","author":[{"given":"Natalia","family":"Gruba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lech","family":"Stachurski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Lesner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bioorg.2026.109818_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"16","key":"10.1016\/j.bioorg.2026.109818_bb0010","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1002\/cncr.33587","article-title":"The ever-increasing importance of cancer as a leading cause of premature death worldwide","volume":"127","author":"Bray","year":"2021","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.bioorg.2026.109818_bb0015","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.1468-0009.2005.00398.x","article-title":"The epidemiologic transition: a theory of the epidemiology of population change. 1971","volume":"83","author":"Omran","year":"2005","journal-title":"Milbank Q."},{"issue":"4","key":"10.1016\/j.bioorg.2026.109818_bb0020","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/jamaoncol.2022.7826","article-title":"Estimates and projections of the global economic cost of 29 cancers in 204 countries and territories from 2020 to 2050","volume":"9","author":"Chen","year":"2023","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.bioorg.2026.109818_bb0025","series-title":"Global Cancer Observatory: Cancer Today","year":"2020"},{"key":"10.1016\/j.bioorg.2026.109818_bb0030","series-title":"Cancer Epidemiology and Prevention","first-page":"977","author":"Silverman","year":"2018"},{"key":"10.1016\/j.bioorg.2026.109818_bb0035","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.eururo.2016.06.010","article-title":"Bladder cancer incidence and mortality: a global overview and recent trends","volume":"71","author":"Antoni","year":"2017","journal-title":"Eur. Urol."},{"key":"10.1016\/j.bioorg.2026.109818_bb0040","doi-asserted-by":"crossref","first-page":"E21","DOI":"10.1097\/NCC.0000000000000606","article-title":"Quality of life in non-muscle-invasive bladder cancer survivors: a systematic review","volume":"42","author":"Jung","year":"2019","journal-title":"Cancer Nurs."},{"key":"10.1016\/j.bioorg.2026.109818_bb0045","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00345-009-0395-z","article-title":"Economic aspects of bladder cancer: what are the benefits and costs?","volume":"27","author":"Sievert","year":"2009","journal-title":"World J. Urol."},{"key":"10.1016\/j.bioorg.2026.109818_bb0050","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s00345-016-1795-5","article-title":"Prognostic value of urinary cytology and other biomarkers for recurrence and progression in bladder cancer: a prospective study","volume":"34","author":"Bell","year":"2016","journal-title":"World J. Urol."},{"key":"10.1016\/j.bioorg.2026.109818_bb0055","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ccr.2004.08.002","article-title":"Focus on bladder cancer","volume":"6","author":"Dinney","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bioorg.2026.109818_bb0060","doi-asserted-by":"crossref","first-page":"104","DOI":"10.5489\/cuaj.4127","article-title":"Prospective evaluation of anxiety, pain, and embarrassment associated with cystoscopy and urodynamic testing in clinical practice","volume":"11","author":"Biardeau","year":"2017","journal-title":"Can. Urol. Assoc. J."},{"key":"10.1016\/j.bioorg.2026.109818_bb0065","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.urolonc.2020.08.016","article-title":"Urinary biomarkers in bladder cancer: A review of the current landscape and future directions","volume":"39","author":"Ng","year":"2021","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.bioorg.2026.109818_bb0070","first-page":"882","article-title":"Accuracy of grading of urothelial carcinoma on urine cytology: an analysis of interobserver and intraobserver agreement","volume":"5","author":"Reid","year":"2012","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.bioorg.2026.109818_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2014.06.008","article-title":"Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer","volume":"33","author":"Yafi","year":"2015","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.bioorg.2026.109818_bb0080","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0090-4295(02)02136-2","article-title":"Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses","volume":"61","author":"Lotan","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.bioorg.2026.109818_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000369357","article-title":"Molecular markers for bladder cancer screening, early diagnosis, and surveillance: the WHO\/ICUD consensus","volume":"94","author":"Schmitz-Dr\u00e4ger","year":"2015","journal-title":"Urol. Int."},{"key":"10.1016\/j.bioorg.2026.109818_bb0090","doi-asserted-by":"crossref","first-page":"922","DOI":"10.7326\/M15-0997","article-title":"Urinary biomarkers for diagnosis of bladder cancer: a systematic review and meta-analysis","volume":"163","author":"Chou","year":"2015","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bioorg.2026.109818_bb0095","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3390\/diagnostics10060383","article-title":"Shedding light on bladder cancer diagnosis in urine","volume":"10","author":"Chan","year":"2020","journal-title":"Diagnostics (Basel)"},{"issue":"3","key":"10.1016\/j.bioorg.2026.109818_bb0100","doi-asserted-by":"crossref","first-page":"217","DOI":"10.4103\/iju.IJU_69_21","article-title":"Apolipoprotein A1 as a novel urinary biomarker for diagnosis of bladder cancer: a systematic review and meta-analysis","volume":"37","author":"Dardeer","year":"2021","journal-title":"Indian J. Urol."},{"issue":"2","key":"10.1016\/j.bioorg.2026.109818_bb0105","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0022-5347(05)64659-9","article-title":"Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors","volume":"168","author":"Eissa","year":"2002","journal-title":"J. Urol."},{"issue":"2","key":"10.1016\/j.bioorg.2026.109818_bb0110","first-page":"1165","article-title":"Diagnostic accuracy of urinary survivin mRNA expression detected by RT-PCR compared with urine cytology in the detection of bladder cancer: A meta-analysis of diagnostic test accuracy in head-to-head studies","volume":"19","author":"Fu","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bioorg.2026.109818_bb0115","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13148-016-0303-5","article-title":"UroMark-a urinary biomarker assay for the detection of bladder cancer","volume":"9","author":"Feber","year":"2017","journal-title":"Clin. Epigenetics"},{"issue":"1","key":"10.1016\/j.bioorg.2026.109818_bb0120","doi-asserted-by":"crossref","first-page":"22149","DOI":"10.1038\/s41598-025-07173-5","article-title":"Diagnostic accuracy of urinary PENK methylation test for urothelial and other cancers: a prospective study","volume":"15","author":"Lee","year":"2025","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.bioorg.2026.109818_bb0125","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/bju.14673","article-title":"Diagnostic accuracy, clinical utility and influence on decision-making of a methylation urine biomarker test in the surveillance of non-muscle-invasive bladder cancer","volume":"123","author":"D\u2019Andrea","year":"2019","journal-title":"BJU Int."},{"issue":"18","key":"10.1016\/j.bioorg.2026.109818_bb0130","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.3390\/diagnostics14182061","article-title":"Analytical validation of Cxbladder\u00ae detect, triage, and monitor: assays for detection and management of urothelial carcinoma","volume":"14","author":"Harvey","year":"2024","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"10.1016\/j.bioorg.2026.109818_bb0135","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jmoldx.2020.10.005","article-title":"UriBLAD: a urine-based gene expression assay for noninvasive detection of bladder cancer","volume":"23","author":"Wang","year":"2021","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.bioorg.2026.109818_bb0140","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.euros.2024.09.001","article-title":"Xpert bladder cancer detection in Emergency Setting Assessment (XESA Project): a prospective, single-centre trial","volume":"71","author":"Sordelli","year":"2024","journal-title":"Eur. Urol. Open Sci."},{"issue":"Suppl. 5","key":"10.1016\/j.bioorg.2026.109818_bb0145","doi-asserted-by":"crossref","first-page":"S546","DOI":"10.21037\/tau.2019.12.41","article-title":"UroSEEK gene panel for bladder cancer surveillance","volume":"8","author":"Wong","year":"2019","journal-title":"Transl. Androl. Urol."},{"key":"10.1016\/j.bioorg.2026.109818_bb0150","unstructured":"AssureMDx | Bladder Cancer Detection | Vesica Health | California [on-line access 7.01.2026]."},{"key":"10.1016\/j.bioorg.2026.109818_bb0155","series-title":"Clinical Diagnosis and Management by Laboratory Methods","first-page":"60","volume":"Vol 1","author":"Henry","year":"1979"},{"key":"10.1016\/j.bioorg.2026.109818_bb0160","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1399-3011.1991.tb00765.x","article-title":"General method for rapid synthesis of multicomponent peptide mixtures","volume":"37","author":"Furka","year":"1991","journal-title":"Int. J. Pept. Protein Res."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109818_bb0165","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0094-0143(05)70231-7","article-title":"Urine cytology. It is still the gold standard for screening?","volume":"27","author":"Brown","year":"2000","journal-title":"Urol. Clin. N. Am."},{"issue":"2","key":"10.1016\/j.bioorg.2026.109818_bb0170","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s40291-013-0023-x","article-title":"Bladder cancer detection and monitoring: assessment of urine- and blood-based marker tests","volume":"17","author":"Goodison","year":"2013","journal-title":"Mol. Diagn. Ther."},{"issue":"8","key":"10.1016\/j.bioorg.2026.109818_bb0175","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.3390\/cancers17081283","article-title":"Novel urinary biomarkers for the detection of bladder cancer","volume":"17","author":"Oyaert","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.bioorg.2026.109818_bb0180","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/S0022-5347(17)47574-4","article-title":"Elastase\u2013does this enzyme play any role in bladder cancer invasion?","volume":"134","author":"Nemoto","year":"1985","journal-title":"J. Urol."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109818_bb0185","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/0006-291X(89)91997-9","article-title":"Elastase activities of human bladder cancer cell lines derived from high grade invasive tumors","volume":"162","author":"Grant","year":"1989","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bioorg.2026.109818_bb0190","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1171065","article-title":"Bladder cancer patients have increased NETosis and impaired DNaseI-mediated NET degradation that can be therapeutically restored in vitro","volume":"14","author":"Herranz","year":"2023","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.bioorg.2026.109818_bb0195","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.3390\/ijms22094483","article-title":"The interplay between oxidative stress, inflammation and angiogenesis in bladder cancer development","volume":"22","author":"Wigner","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"54","key":"10.1016\/j.bioorg.2026.109818_bb0200","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.21565","article-title":"Inflammatory microenvironment in the initiation and progression of bladder cancer","volume":"8","author":"Sui","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.bioorg.2026.109818_bb0205","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/jb\/mvab075","article-title":"Elastolytic activity is associated with inflammation in bladder cancer","volume":"170","author":"Gruba","year":"2021","journal-title":"J. Biochem."},{"issue":"25","key":"10.1016\/j.bioorg.2026.109818_bb0210","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.24947","article-title":"Diagnostic and prognostic biomarker potential of kallikrein family genes in different cancer types","volume":"9","author":"Tailor","year":"2018","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.bioorg.2026.109818_bb0215","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/1878-0261.12587","article-title":"The molecular function of kallikrein-related peptidase 14 demonstrates a key modulatory role in advanced prostate cancer","volume":"14","author":"Kryza","year":"2020","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.bioorg.2026.109818_bb0220","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.740796","article-title":"Carfilzomib: a promising proteasome inhibitor for the treatment of relapsed and refractory multiple myeloma","volume":"11","author":"Jayaweera","year":"2021","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.bioorg.2026.109818_bb0225","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1134\/S002689331403011X","volume":"48","author":"Kondakova","year":"2014","journal-title":"Mol. Biol. (Mosk)"},{"issue":"15","key":"10.1016\/j.bioorg.2026.109818_bb0230","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1111\/febs.13786","article-title":"Bladder cancer detection using a peptide substrate of the 20S proteasome","volume":"283","author":"Gruba","year":"2016","journal-title":"FEBS J."},{"key":"10.1016\/j.bioorg.2026.109818_bb0235","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1186\/1471-2407-9-377","article-title":"Loss of prostasin (PRSS8) in human bladder transitional cell carcinoma cell lines is associated with epithelial-mesenchymal transition (EMT)","volume":"9","author":"Chen","year":"2009","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.bioorg.2026.109818_bb0240","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00432-016-2301-6","article-title":"Downregulated KLK13 expression in bladder cancer highlights tumor aggressiveness and unfavorable patients\u2019 prognosis","volume":"143","author":"Tokas","year":"2017","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.bioorg.2026.109818_bb0245","first-page":"269","article-title":"Kallikrein-related peptidases in prostate cancer: from molecular function to clinical application","volume":"25","author":"Fuhrman-Luck","year":"2014","journal-title":"EJIFCC"},{"issue":"1","key":"10.1016\/j.bioorg.2026.109818_bb0250","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s12672-023-00620-7","article-title":"Pyroptosis in urinary malignancies: a literature review","volume":"14","author":"Wang","year":"2023","journal-title":"Discov. Oncol."},{"issue":"24","key":"10.1016\/j.bioorg.2026.109818_bb0255","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adt8697","article-title":"Caspase-1-dependent pyroptosis converts \u03b1SMA+ CAFs into collagen-IIIhigh iCAFs to fuel chemoresistant cancer stem cells","volume":"11","author":"Gao","year":"2025","journal-title":"Sci. Adv."},{"issue":"21","key":"10.1016\/j.bioorg.2026.109818_bb0260","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1182\/blood.V120.21.3405.3405","article-title":"Biomarker profiling of bladder cancer patients undergoing radical cystectomy. relevance of thrombotic and inflammatory processes","volume":"120","author":"Abro","year":"2012","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.bioorg.2026.109818_bb0265","first-page":"193","article-title":"Aktywno\u015b\u0107 bia\u0142ka C we krwi chorych na raka pecherza moczowego [The activity of protein C in the blood of patients with bladder carcinoma]","volume":"2","author":"Iwan-Zietek","year":"1997","journal-title":"Pol. Merkur. Lekarski"},{"key":"10.1016\/j.bioorg.2026.109818_bb0270","article-title":"Evaluation of proteolytic activity and serine proteases distribution in plasma from patients with bladder cancer","volume":"10","author":"Synelnyk","year":"2023","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.bioorg.2026.109818_bb0275","first-page":"386","article-title":"Cathepsin D and B activity in the serum of patients with urothelial bladder cancer","volume":"36","author":"Guszcz","year":"2014","journal-title":"Pol. Merkur. Lekarski"},{"issue":"2","key":"10.1016\/j.bioorg.2026.109818_bb0280","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0090-4295(01)01517-5","article-title":"Cathepsins B, H, and L activities in urine of patients with transitional cell carcinoma of the bladder","volume":"59","author":"Staack","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.bioorg.2026.109818_bb0285","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-2490-6-19","article-title":"Combined determination of plasma MMP2, MMP9, and TIMP1 improves the non-invasive detection of transitional cell carcinoma of the bladder","volume":"6","author":"Staack","year":"2006","journal-title":"BMC Urol."},{"issue":"5","key":"10.1016\/j.bioorg.2026.109818_bb0290","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/his.15287","article-title":"Advances, recognition, and interpretation of molecular heterogeneity among conventional and subtype histology of urothelial carcinoma (UC): a survey among urologic pathologists and comprehensive review of the literature","volume":"85","author":"Lobo","year":"2024","journal-title":"Histopathology"},{"key":"10.1016\/j.bioorg.2026.109818_bb0295","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.817086","article-title":"Identification of prognostic biomarkers for bladder cancer based on DNA methylation profile","volume":"9","author":"Zhang","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109818_bb0300","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s40364-023-00488-3","article-title":"Integrative multi-omics analysis depicts the methylome and hydroxymethylome in recurrent bladder cancers and identifies biomarkers for predicting PD-L1 expression","volume":"11","author":"Shi","year":"2023","journal-title":"Biomark. Res."},{"issue":"3","key":"10.1016\/j.bioorg.2026.109818_bb0305","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1080\/07357907.2022.2028805","article-title":"CD274 (PD-L1) methylation is an independent predictor for bladder cancer patients' survival","volume":"40","author":"Xu","year":"2022","journal-title":"Cancer Invest."},{"issue":"3","key":"10.1016\/j.bioorg.2026.109818_bb0310","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/cncy.22657","article-title":"DNA methylation analysis in urinary samples: a useful method to predict the risk of neoplastic recurrence in patients with urothelial carcinoma of the bladder in the high-risk group","volume":"131","author":"Pierconti","year":"2023","journal-title":"Cancer Cytopathol."},{"issue":"15","key":"10.1016\/j.bioorg.2026.109818_bb0315","doi-asserted-by":"crossref","first-page":"12489","DOI":"10.3390\/ijms241512489","article-title":"Bladder Epicheck test: a novel tool to support urothelial carcinoma diagnosis in urine samples","volume":"24","author":"Fiorentino","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.bioorg.2026.109818_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2020.06.018","article-title":"The combination cytology\/epichek test in non muscle invasive bladder carcinoma follow-up: Effective tool or useless expence?","volume":"39","author":"Pierconti","year":"2021","journal-title":"Urol. Oncol."},{"issue":"12","key":"10.1016\/j.bioorg.2026.109818_bb0325","doi-asserted-by":"crossref","first-page":"6750","DOI":"10.3390\/ijms25126750","article-title":"Programmed cell death ligand 1 (PD-L1) immunohistochemical expression in advanced urothelial bladder carcinoma: an updated review with clinical and pathological implications","volume":"25","author":"German\u00e0","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.bioorg.2026.109818_bb0330","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1055\/s-0043-1776875","article-title":"The complex role of thrombin in cancer and metastasis: focus on interactions with the immune system","volume":"50","author":"Aleksandrowicz","year":"2024","journal-title":"Semin. Thromb. Hemost."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826003548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826003548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T13:24:57Z","timestamp":1775913897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826003548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":66,"alternative-id":["S0045206826003548"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109818","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utility of FRET substrates in bladder cancer diagnosis","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109818","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109818"}}